Risk of muscle toxicity events for daptomycin with and without statins: Analysis of the Japanese Adverse Event Report database.

MLA

Yamada, Tomoyuki, et al. “Risk of Muscle Toxicity Events for Daptomycin with and without Statins: Analysis of the Japanese Adverse Event Report Database.” Basic & Clinical Pharmacology & Toxicology, vol. 129, no. 3, Sept. 2021, pp. 268–72. EBSCOhost, https://doi.org/10.1111/bcpt.13618.

APA

Yamada, T., Mitsuboshi, S., Suzuki, K., Nishihara, M., & Uchiyama, K. (2021). Risk of muscle toxicity events for daptomycin with and without statins: Analysis of the Japanese Adverse Event Report database. Basic & Clinical Pharmacology & Toxicology, 129(3), 268–272. https://doi.org/10.1111/bcpt.13618

Chicago

Yamada, Tomoyuki, Satoru Mitsuboshi, Kaoru Suzuki, Masami Nishihara, and Kazuhisa Uchiyama. 2021. “Risk of Muscle Toxicity Events for Daptomycin with and without Statins: Analysis of the Japanese Adverse Event Report Database.” Basic & Clinical Pharmacology & Toxicology 129 (3): 268–72. doi:10.1111/bcpt.13618.